title: Leukoencephalitis after recombinant hepatitis B vaccine.
authors.forename: R
authors.initials: R
authors.lastname: Manna
authors.forename: A
authors.initials: A
authors.lastname: De Santis
authors.forename: A
authors.initials: A
authors.lastname: Oliviero
authors.forename: A
authors.initials: A
authors.lastname: Carnevale
authors.forename: S
authors.initials: S
authors.lastname: Caputo
authors.forename: M
authors.initials: M
authors.lastname: Pahor
authors.forename: A
authors.initials: A
authors.lastname: Laudisio
authors.forename: G
authors.initials: G
authors.lastname: Gasbarrini
mesh_terms: D000293:Adolescent; D000914:Antibodies, Viral / Q000097:blood; D018792:Encephalitis, Viral / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000276:immunology; D017325:Hepatitis B Vaccines / Q000009:adverse effects*; D006801:Humans; D008279:Magnetic Resonance Imaging; D014614:Vaccines, Synthetic / Q000009:adverse effects*
chemical_list: D000914:Antibodies, Viral; C075654:Engerix-B; D017325:Hepatitis B Vaccines; D014614:Vaccines, Synthetic